The dose-response relationship appears across the depth-psychology corpus as a structuring principle that bridges pharmacological precision and phenomenological complexity. Rather than treating dosage as a mere quantitative variable, the authors engaging this concept reveal that dose-response logic imports assumptions about linearity, threshold effects, and biological determinism into domains — psychedelic research, trauma epidemiology, addiction treatment, and nature therapy — where such assumptions require examination. Rick Strassman’s DMT investigations represent the most sustained engagement, deploying classical dose-response methodology (placebo, low, medium, high) to chart the gradient from mild visionary phenomena to full ontological dissolution, while simultaneously discovering that subjective experience resists simple proportionality. Felitti’s ACE study translates the concept into a psychosocial register, demonstrating that cumulative childhood adversity produces graded increases in adult health risk that function like a toxic exposure curve. Simpson’s treatment-outcome research borrows the idiom for therapeutic dose — duration and intensity of engagement — while Bettmann applies it to nature exposure as mental health intervention. Across these contexts, the term anchors the aspiration toward quantitative rigor while the evidence repeatedly surfaces non-linearities, threshold phenomena, individual variability, and qualitative discontinuities that exceed the model’s explanatory reach.
a strong relationship between the number of childhood exposures and the number of health risk factors for leading causes of death in adults
Felitti demonstrates a graded dose-response relationship in which cumulative adverse childhood experiences predict escalating clusters of adult health risk factors with near-linear proportionality.
Most dose-response studies of any new drug give volunteers one ‘high’ dose, one ‘low’ dose, and one or two ‘medium’ doses in order to describe the entire spectrum of effects.
Strassman articulates the classical pharmacological dose-response design as the explicit methodological framework governing his DMT trials, establishing placebo-controlled graduated dosing to map the full phenomenological spectrum.
, DMT: The Spirit Molecule: A Doctor’s Revolutionary Research into the Biology of Near-Death and Mystical Experiences, 2001thesis
Most dose-response studies of any new drug give volunteers one ‘high’ dose, one ‘low’ dose, and one or two ‘medium’ doses in order to describe the entire spectrum of effects.
This parallel edition passage confirms Strassman’s use of canonical dose-response trial architecture as the scaffold for investigating psychedelic phenomenology in human subjects.
, DMT: The Spirit Molecule, 2001thesis
I could delay this process by performing dose-response and perhaps tolerance studies with other drugs, such as psilocybin and LSD.
Strassman explicitly frames dose-response and tolerance studies as the next logical investigative step, signaling how deeply this paradigm structured his broader research programme across multiple psychedelics.
, DMT: The Spirit Molecule: A Doctor’s Revolutionary Research into the Biology of Near-Death and Mystical Experiences, 2001supporting
As the dose-response study neared completion, I needed to decide how to design subsequent grant applications and study designs.
Strassman reveals how the dose-response study served as the institutional and methodological anchor around which subsequent psychedelic research designs were organised.
, DMT: The Spirit Molecule, 2001supporting
Revealing a dose-dependent relationship between resistance training intensity and craving reduction
Li et al. extend dose-response logic to exercise intervention in methamphetamine use disorder, demonstrating that training intensity produces graded reductions in drug craving analogous to pharmacological dose-response curves.
, Exercise as a Promising Adjunct Treatment for Methamphetamine Addiction: Advances in Understanding Neuroplasticity and Clinical Applications, 2025supporting
when participants reported at least 120 total minutes of interval-delivered nature exposure over a week, they had greater likelihood of reporting good health and well-being
Bettmann applies dose-response reasoning to nature exposure, identifying a threshold quantity of weekly contact with natural environments beyond which mental health benefits become statistically reliable.
, A Systematic Review and Meta-Analysis on the Effect of Nature Exposure Dose on Adults with Mental Illness, 2025supporting
use for cocaine-dependent methadone patients: A dose-response relationship.
Simpson’s citation of a dose-response study for cocaine-dependent methadone patients imports the pharmacological model directly into substance abuse treatment outcome research, framing therapeutic engagement as a dosed intervention.
, A conceptual framework for drug treatment process and outcomes, 2004supporting
recent explorations into the ‘dose-effect’ of individual psychotherapy shed some light on the question of duration of therapy.
Yalom translates the dose-response concept into group psychotherapy duration research, applying ‘dose-effect’ terminology to justify empirically derived session-count thresholds for different therapeutic goals.
, The Theory and Practice of Group Psychotherapy, Fifth Edition, 2008supporting
our first dose-response study volunteer: DMT-1. He began speaking within 2 minutes of getting his first non-blind low dose
Strassman documents the experiential onset data from the initial dose-response volunteer, illustrating how the structured dosing protocol generated qualitatively distinct visionary content at different levels of administration.
, DMT: The Spirit Molecule: A Doctor’s Revolutionary Research into the Biology of Near-Death and Mystical Experiences, 2001supporting
I think the best high dose is between 0.2 and 0.6.
A volunteer’s in-session commentary on optimal dose range provides phenomenologically grounded participant feedback on the dose-response gradient from within the study itself.
, DMT: The Spirit Molecule: A Doctor’s Revolutionary Research into the Biology of Near-Death and Mystical Experiences, 2001aside
It was hypothesized that a threshold of DHA and EPA would be identified, above which the majority of patients would be non-relapsers.
Buydens-Branchey applies threshold dose-response logic to plasma fatty acid levels, hypothesising that biological nutrient concentrations predict relapse vulnerability in a graded, quantifiable manner.
, Low Plasma Levels of Docosahexaenoic Acid Are Associated with an Increased Relapse Vulnerability in Substance Abusers, 2009aside